Preferential inhibition of L- and N-type calcium channels in the rat hippocampal neurons by cilnidipine

Brain Research

Volumn 854, Issue 1-2, 2000, Pages 6-10

  Murai, Yoshinaka ^a   Uneyama, Hisayuki ^b   Ishibashi, Hitoshi ^c   Takahama, Kazuo ^c   Akaike, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Basic Research Institute   (Japan)

^c Fac Pharmaceutical Sci   (Japan)

Author keywords

Cilnidipine; Hippocampal CA1 region; HVA Ca2+ channel; Nystatin perforated patch; Pyramidal neuron

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CILNIDIPINE; NYSTATIN;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; VOLTAGE CLAMP;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; DIHYDROPYRIDINES; ELECTROPHYSIOLOGY; HIPPOCAMPUS; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

EID: 0033972645     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02295-7     Document Type: Article

References (20)

1. Akaike N., Harata N. Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn. J. Physiol. 44:1994;433-473.
2. Birnbaumer K.P., Cambell K.P., Catterall W.A., Harold M.M., Hofmann F., Horne W.A., Mori Y., Schwartz A., Snutch T.P., Tanabe T., Tsien R.W. The naming of voltage-gated calcium channels. Neuron. 13:1994;505-506.
3. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic change. Trends Neurosci. 11:1988;465-469.
4. ++ channel in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 280:1997;1184-1191.
5. Hatashita S., Hoff J.T. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke. 21:1990;582-588.
6. Hosono M., Iida H., Ikeda K., Hayashi Y., Dohmoto H., Hashiguchi Y., Yamamoto H., Watanabe N., Yoshimoto R. In vivo and ex vivo Ca-antagonistic effect of 2-methoxyethyl(E)-3-phenyl-2-propen-1-yl(±)-1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) pyridine-3,5-dicarboxylate (FRC-8653), a new dihydropyridine derivative. J. Pharmacobio-Dyn. 409:1992;547-553.
7. 2+ channels in freshly dissociated rat hippocampal neurons. J. Neurophysiol. 74:1995;1028-1036.
8. 2+ channels in rat CNS neurones. NeuroReport. 6:1995;1621-1624.
9. 2+ channels in rat CNS neurones. NeuroReport. 8:1997;853-857.
10. 2+ channels in rat hippocampal CA1 pyramidal. Brain Res. 813:1998;121-127.
11. Izumiya K., Kogure K. Prevention of delayed neuronal death in gerbil hippocampus by ion channel blockers. Stroke. 19:1988;1003-1007.
12. Lipscombe D., Kongsamut S., Tsien R.W. α-Adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium channel. Nature. 340:1989;639-642.
13. Matsuzawa Y., Oikawa I., Gonsho A., Yamamoto K., Ozaki M. Absorption, distribution and excretion of (±)-2-methoxyethyl-3-phenyl-2(E)-propenyl-1,4-dihydro-2,6-dimethyl-4-(3- nitrophenyl)-3,5-pyridine decarboxylate (FRC-8653) after single administration of rats. Jpn. Pharmacol. Ther. 20:1992;111-129.
14. Nakagawa T., Shirasaki T., Wakamori M., Fukuda A., Akaike N. Excitatory amino acid response in isolated nucleus tractus solitarii neurons of the rat. Neurosci. Res. 8:1990;114-123.
15. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15:1995;2995-3012.
16. Rhee J.S., Ishibashi H., Akaike N. Calcium channels in the GABAergic presynaptic nerve terminals projecting to Meynert neurons of the rat. J. Neurochem. 72:1999;800-807.
17. 2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br. J. Pharmacol. 122:1997;37-42.
18. Watanabe K., Dozen M., Hayashi Y. Effect of cilnidipine (FRC-8653) on autoregulation of cerebral blood flow. Nippon Yakugaku Zasshi. 106:1995;393-399.
19. Westenbroek R.E., Hell J.W., Warner C., Dubel S.J., Snutch T.P., Catterall W.A. Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron. 9:1992;1099-1115.
20. Yoshimoto R., Dohmoto H., Yamada K., Goto A prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cilnidipine. Jpn. J. Pharmacol. 56:1991;225-229.